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ㅋ
Relationship between Helicobacter pylori (H. pylori) and gastroesophageal reflux disease (GERD) is controversial. We aimed to 
review the possible relationship between H. pylori infection and GERD. Epidemiological data indicate an inverse relationship be-
tween frequency of H. pylori infection and prevalence of GERD and its complications like Barrett’s esophagus and esophageal 
adenocarcinoma. H. pylori eradication in patients with peptic ulcer disease may be associated with increased risk of develop-
ment of GERD compared with untreated patients. Infection with cagA bearing strains of H. pylori was associated with less se-
vere GERD including endoscopic esophagitis, possibly due to pangastritis leading to hypochlorhydria. Recent studies on in-
flammatory markers (IL-1β  and IL-1RN) suggest pro-inflammatory genotypes to be protective against development of severe 
GERD, especially in patients with H. pylori infection. Identification of candidate genes playing an important role in gastric acid 
secretion and visceral hypersensitivity to the esophageal epithelium might help in early detection of individuals susceptible to 
develop GERD. Interplay between H. pylori and host factors play an important role in the pathogenesis of GERD. 
(J Neurogastroenterol Motil 2010;16:243-250)
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Introduction
Gastroesophageal reflux disease (GERD) is a common con-
dition, often associated with impairment in health-related qual-
ity of life.
1 Esophageal acid exposure in patients with GERD 
may be severe enough to cause endoscopically visible mucosal 
damage (erosive esophagitis), which is graded by Los Angeles 
classification,
2 peptic esophageal stricture, and Barrett’s esoph-
agus (BE). In a good proportion of patients, there is no endo-
scopically visible mucosal damage of esophageal mucosa in spite 
of symptoms of GERD and esophageal acid exposure. This 
condition is termed as endoscopy-negative reflux disease 
(ENRD). Recent reports indicate ENRD to be quite common 
all over the world.
3
Several factors may influence the severity of GERD. 
Esophageal acid exposure not only depends on reflux of gastric 
contents into esophagus and failure of esophagus to clear it by 
peristaltic contractions but also on pH of the refluxed gastric 
juice.
4,5 pH of gastric juice depends on acid secretory capacity of 
oxyntic or parietal cells. Helicobacter pylori (H. pylori) infection is 
common in many parts of the world. Since GERD is also a com-Uday C Ghoshal and Dipti Chourasia
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mon condition, co-existence of this disease and H. pylori infection 
is quite expected. What could be the relationship between H. py-
lori infection and occurrence and severity of GERD? Most stud-
ies suggest that H. pylori may protect against development of 
GERD or may reduce its severity,
6-9 however, a few studies do 
suggest that it may aggravate GERD.
10,11 Supportive evidences 
discussed below will elucidate the possible relationship between 
GERD and H. pylori.  
Epidemiological Studies Regarding
 the Relationship Between GERD
 and H. pylori Infection
Frequency of H. pylori infection is lower in people from de-
veloped countries such as North America, Western Europe and 
Australia
12-14 whereas that of GERD and its complications are 
more frequent among them.
15-17 In contrast, frequency of H. pylo-
ri infection is higher in people from developing nations such as 
South America, Eastern Europe, Africa, China and India
18-22 
while that of GERD and its severity is lower among them.
19,23-26 
Furthermore, there is decline in incidence of peptic ulcer disease 
and distal gastric carcinoma globally but increase in GERD and 
its complications such as BE and esophageal adenocarcinoma 
(EAC).
6,27,28 Moreover, frequency of H. pylori infection is also 
decreasing worldwide due to better hygiene and increasing use of 
antibiotics.
29 Therefore, one can assume a possible negative rela-
tion between H. pylori infection and frequency and severity of 
GERD.
Asian perspective
Asian data also support an inverse relationship between 
GERD and its complications and H. pylori infection. Data from 
Korea showed that prevalence of reflux esophagitis was 7.9% and 
majority of patients had mild grades of disease (Los Angeles clas-
sification A and B),
30 and frequency of BE was low (0.84%).
31 A 
study from China suggested that the prevalence of erosive esoph-
agitis and BE was 4.3% and 1.0%, respectively and H. pylori was 
negatively associated with erosive esophagitis.
32 One of the rea-
sons for increase in prevalence of GERD in Japan in recent years 
is thought to be due to decrease in H. pylori infection rate
33 and 
absence of H. pylori infection was one of the risk factors for occur-
rence of GERD in another study.
34 Hence, most studies suggest 
a possible protective role of H. pylori against GERD.
Evidences From H. pylori
 Eradication Studies
It is well-established that eradication of H. pylori heals peptic 
ulcer and prevents its recurrence. Increased severity of GERD 
and its complications such as BE after successful eradication of 
H. pylori in patients with or without peptic ulcer has been docu-
mented in several studies.
7,8,35-37 Others reported de novo develop-
ment or exacerbation of GERD after treatment of H. pylori
38,39 
particularly among Asians compared to North Americans and 
Europeans.
40 Development of GERD following eradication of 
H. pylori may reflect an increase in the acidity of the refluxate su-
perimposed on pre-existing abnormalities in gastroesophageal 
motility. Conversely, some studies did show beneficial effect of 
H. pylori eradication on symptoms of GERD.
41,42
In a meta-analysis by Yaghoobi et al,
43 though frequency of 
GERD was not found to be higher after eradication of H. pylori 
among dyspeptic patients, there was two folds increased risk of its 
development with successful eradication among patients with 
peptic ulcer compared to untreated controls. What could be the 
explanation for this? It is possible that the dyspeptic patients al-
ready had irreversible reduction in gastric acid secretion due to 
pangastritis in contrast to those with peptic ulcer, who are known 
to have increased parietal cell mass causing hyperchlorhydria. 
This meta-analysis therefore, may suggest a possible protective 
role of H. pylori infection against the development of GERD at 
least among patients with peptic ulcer.
Asian perspective
Data from Asia on this issue is scant. A study from Japan 
showed improvement in pre-existing reflux esophagitis after H. py-
lori eradication in patients with GERD associated with duodenal 
ulcer.
44 These results are contradictory to most other studies. 
Fujiwara explained the mechanism of such results as follows: (1) 
normalization of gastric acidity in patients with duodenal ulcer 
might play an important role, (2) secondly, heartburn and/or acid 
regurgitation might be confused with symptoms of peptic ulcer dis-
ease; hence, the symptoms might be felt as improved after the cure 
of H. pylori infection and (3) lastly, if peptic ulcer itself directly or 
indirectly induced GERD, healing of the ulcer might result in im-
provement of GERD.
33 Hence, patients having GERD with peptic 
ulcer were benefited by the H. pylori eradication therapy. Further-
more, in Japan H. pylori should be eradicated in patients with 
GERD as well due to high incidence of gastric cancer.
45 Gastroesophageal Reflux Disease and Helicobacter pylori
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Figure 1. Possible role of various fac-
tors including H. pylori in pathoge-
nesis of gastroesophageal reflux disease.
Mechanism of Gastric Acid Alteration
 by H. pylori and Its Relationship
 With GERD
H. pylori infection leads to gastritis that might alter gastric 
acid secretion. The degree and extent of gastritis may be related 
to host genetic or agent (H. pylori strains) factors. 
1. H. pylori, gastritis and gastric acid secretion altering 
GERD severity
H. pylori may influence gastric acid secretion in 2 ways: (1) 
limited inflammation in the gastric antrum is associated with de-
struction of somatostatin secreting D-cells.
46 Thus, there is loss of 
negative feedback on gastric acid secretion resulting in increased 
parietal cell mass and hyperchlorhydria, which may increase se-
verity of GERD and (2) pangastritis (more often associated with 
cytotoxin-associated gene A [cagA] and vacuolating cytotoxin 
[VacAs1] bearing strains) leads to destruction of acid secreting 
parietal cells of gastric corpus, causing gastric atrophy with con-
sequent hypo- or achlorhydria (Fig. 1); this may reduce the se-
verity of GERD and its complications. A review by Sharma and 
Vakil also suggested a negative association between the preva-
lence of H. pylori infection especially cagA bearing strains and BE 
and EAC.
28 
A study from Taiwan showed that only 33% of 276 patients 
with reflux esophagitis had H. pylori infection compared with 
67.5% of 378 with normal esophagus. Triple virulent (cagA, 
blood-group antigen-binding adhesion gene [babA2] and vacAs1a) 
genotype of H. pylori was also uncommon among patients with re-
flux esophagitis.
47 In a study from Hong Kong, the prevalence of 
H. pylori infection among 225 patients with GERD was 34%; H. 
pylori infected patients had less severe esophagitis than those 
without it. Of those infected with H. pylori, 70%, 76% and 78% 
of ENRD, erosive oesophagitis and control subjects, respectively 
were cagA positive.
48 Protective effect of cagA positive strains of 
H. pylori against GERD has also been shown in Iran.
49 Another 
multi-ethnic study from Malaysia suggested that cagA-positive 
strains of H. pylori was associated with reduced severity of 
GERD among Indians.
50 As prevalence of cagA bearing strains of 
H. pylori is high in some developing countries,
51 frequent occur-
rence of hypochlorhydria may protect against development of se-
vere GERD and its complications in these areas of the world.
2. Endoscopic severity of GERD and H. pylori infection
Patients with severe GERD (higher Los Angeles grades) are 
less often infected with H. pylori.
3,52,53 Also, cagA bearing strains 
of H. pylori is more frequent in patients with ENRD than those 
with endoscopic reflux disease and its sequel,
54 suggesting the 
protective role of these strains of bacteria against development of 
severe GERD. 
Host Factors
Final outcome following exposure to a disease-causing agent 
is also influenced by the host factors. Not only the environmental Uday C Ghoshal and Dipti Chourasia
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or dietary factors, but host physiological as well as genetic factors 
may play important role in the pathogenesis of GERD. Role of 
host physiological factors, such as hypotensive lower esophageal 
sphincter, transient lower esophageal sphincter relaxations, de-
layed gastric emptying, presence of hiatus hernia, hypoperistalsis 
of esophagus are well established in pathogenesis of GERD.
55,56 
However, there is still inadequate literature on host genetic fac-
tors, which may influence development of GERD. Also, the 
clearance of H. pylori may be related to host genetic factors in ad-
dition to differences between strains.
57
Importance of the genetic factors in GERD is supported by 
recent reports that showed that there is increased concordance for 
GERD in monozygotic twin pairs as compared to dizygotic pairs, 
indicating genetic rather than shared environmental effect.
58,59 
Limited studies have shown that IL-1B-511C allele,
60 IL-1B-31T 
allele,
61 G protein beta 3 subunit 825T allele,
62 IL-1RN + 2018 
2/2 genotype,
61 2/2 genotype of IL-10-1082,
63 homozygous ex-
tensive of CYP2C19,
64 b allele (val
105) of glutathione S-trans-
ferase P1,
65,66 A/A genotype of cyclin D1 (CCND1) G870A
67 
and homozygous variant of Xeroderma pigmentosum comple-
mentary group C poly (AT) insertion/deletion polymorphism 
gene
68 are the potential risk factors for either GERD or its com-
plications such as BE and EAC. 
Possible Molecular Mechanisms
1. H. pylori and gastric acid alteration
H. pylori infection induces a substantial inflammatory re-
action in the gastric mucosa with recruitment of leukocytes and 
over-expression and release of pro-inflammatory cytokines. This 
inflammation may be due to the secreted proteins from H. pylori, 
which initiate a cascade of signaling events within the host cells 
resulting in up regulation of several inflammatory mediators. 
Various bacterial factors, which may reduce gastric acid secretion 
and thereby severity of GERD are as follows: (1) VacA, espe-
cially the virulent form s1m1, inhibits gastric acid secretion by 
disrupting the apical membrane-cytoskeletal interaction in gastric 
parietal cells
69: this may reduce esophageal acid exposure; (2) 
bacterial lipopolysaccharides
70 reduces gastric acid secretion 
through prostaglandin system
71 and by inhibition of H
+/K
+- 
ATPase enzymatic function or changes in cytoskeletal rearrange-
ments in H
+/K
+-ATPase subunits rather than by down-regu-
lation of transcriptional or translational events
72; (3) CagA pro-
tein, encoded by cagA gene, is a part of cag pathogenicity island. 
This is translocated into the host cells by Type-IV secretion 
apparatus. Once translocated, it undergoes tyrosine phosphor-
ylation at the Glu-Pro-Ile-Tyr-Ala motif. The presence of a sin-
gle Glu-Pro-Ile-Tyr-Ala motif is necessary for the membrane lo-
calization of CagA.
73 CagA injection into the host gastric epi-
thelial cell can induce NF-κB activation and IL-8 production.
74 
Thus, infection with cagA positive strains may lead to more in-
flammation in the stomach, causing hypochlorhydria; (4) Other 
H. pylori proteins, such as outer membrane inflammatory protein, 
is considered to be important in stimulation of IL-8 secretion, 
even in cag-negative strains, though to a much lesser extent
75 and 
 
(5) H. pylori neutrophil activating protein can induce neutrophils 
to produce reactive oxygen radicals damaging gastric epithe-
lium.
76
2. Genetic factors in susceptibility to GERD 
Limited studies have shown that host genetic factors that may 
influence development of GERD include genes, which may alter 
gastric acid secretion (pro and anti-inflammatory factors and 
those involved in acid secretory pathway),
60,77 DNA repair path-
way (for BE and EAC),
68,78 carcinogen detoxification pathway 
(for EAC),
65,79,80 cell cycle regulatory pathway
67,81 and visceral 
hypersensitivity
62 to the refluxed acid in esophagus (Fig. 1). 
Recently, visceral hypersensitivity has been shown to be involved 
in the pathogenesis of GERD. Patients with GERD may have 
normal esophageal acid exposure, but their esophageal mucosa 
can be more sensitive to the acid reflux, leading to heartburn and 
erosive esophagitis due to visceral neural pathway dysfunc-
tion.
62,82,83 It is also elucidated that one of the major reasons for 
heartburn among patients with ENRD may be related to esoph-
ageal visceral hypersensitivity.
84,85 A recent  study revealed role of 
host genetic polymorphism of G-protein beta 3 subunit gene 
(G-protein-coupled receptors intervene the response to acid, neu-
rotransmitters and humoral factors transforming esophageal sen-
sory function) in the enhanced perception of reflux events.
62 
However, more research is needed on several other candidate 
genes, which could be potentially involved in the above men-
tioned pathways.
In summary, infection with H. pylori may lead to gastric in-
flammatory response, which could be either antral or corpus, de-
pending on the H. pylori strain and host genetic and environ-
mental factors. Gastroesophageal Reflux Disease and Helicobacter pylori
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3. Interplay of host genetic factors, H. pylori and intes-
tinal helminthes 
Since H. pylori is an extra-cellular organism, a Th2-cell re-
sponse (IL-4, IL-5, IL-10, IL-13 and TGF-β) would favor the 
host to clear the bacteria and prevent occurrence of chronic 
infection. Paradoxically, H. pylori-specific gastric mucosal T cells 
generally present a Th1 phenotype (IFN-γ, IFN-β, TNF, IL-2 
and IL-1β; cell mediated immune response).
86 It has been shown 
that infection with intestinal helminthes induces Th2-associated 
IgG1 responses to H. pylori infection.
87 Hence, intestinal hel-
minthes infection may clear the infection by promoting 
Th2-polarizing immune responses to H. pylori. Some of these cy-
tokine polymorphisms have been shown to affect the degree of 
gastritis.
88-94
In developing nations, prevalence of H. pylori infection as 
well as that of helminthes is high because of poor hygienic 
conditions. If an individual gets an infection with helminthes 
first, they will have Th2 predominant cytokine profile, hence pre-
venting persistent H. pylori colonization. On the other hand, if an 
individual has concomitant infection with H. pylori and hel-
minthes (the possibility of which is more common), they might 
show an intermediate Th1 and Th2 cytokine profile. Thus, a bal-
ance between Th1 and Th2 responses may be important in de-
gree of persistence of H. pylori infection. This might decide the 
degree of gastric inflammation and hence, the severity of GERD.
H. pylori infection also activates expression of chemokines 
such as IL-8 and Gro-α . But, their expression is dependent on 
the corresponding expression of their receptors (CXCR1 and 
CXCR2) on neutrophils.
95 IL-8 may influence development of 
gastritis and duodenal ulcer in patients with H. pylori in-
fection.
96,97
Possible role of other factors such as Gro-α, monocyte che-
moattractant protein-1 (MCD-1) and CXCR1 and CXCR2 re-
ceptors in pathogenesis of H. pylori infection and GERD can be 
studied. These molecular mechanisms suggest a complex inter-
play between various host factors, agent and environmental fac-
tors, which decides the final outcome of the disease.
Conclusion
Most epidemiological as well as eradication studies suggests 
a possible protective role of H. pylori infection against GERD. 
Recent data on the role of host genetic factors suggest possible 
mechanism of influence of H. pylori in the pathogenesis of 
GERD. Latest studies targeting the role of inflammatory mark-
ers (IL-1B and IL-1RN) suggest that presence of the pro-in-
flammatory genotypes are associated with less severe GERD.
60,61,77 
Polymorphism studies on genes for visceral hypersensitivity, 
GNB3 also supports that patients with GERD experience en-
hanced perception of reflux events.
62 Hence, interplay between 
both agent (H. pylori) as well as host factors play an important 
role in the pathogenesis of GERD. 
Study of role of host genetic factors in the pathogenesis of 
GERD will be the major thrust area for research in near future, 
as there is scanty data on it. Identification of candidate genes 
playing role in gastric acid secretion and visceral hypersensitivity 
to the esophageal epithelium might help in early detection of in-
dividuals susceptible to develop GERD. Furthermore, a simulta-
neous study of these genetic polymorphisms with H. pylori in-
fection, dietary and life style factors such as obesity,
98 presence of 
gall stones,
99 smoking,
98 and conditions like chronic laryngitis
100 
and chronic obstructive pulmonary disease,
101 which are known 
to be associated with GERD, would be important in evaluating 
their combined effect on risk of GERD. This may help to under-
take preventive strategies for individuals at risk through life style 
changes.
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